Abstract
In a previous immunohistochemical (IHC) study, we documented the reaction of lung tissue vessels to hypoxia through the immunodetection of HIF1-α protein, a key regulator of cellular response to hypoxic conditions. Findings showing that asphyxia deaths are associated with an increase in the number of mast cell (MC)-derived tryptase enzymes in the blood suggests that HIF1-α production may be correlated with MC activation in hypoxic conditions. This hypothesis prompted us to investigate the possible role of pulmonary MC in acute asphyxia deaths. Lung of 47 medico-legal autopsy cases (35 asphyxia/hypoxia deaths, 11 controls, and 1 anaphylactic death) were processed by IHC analysis using anti-CD117 (c-Kit) antibody to investigate peri-airway and peri-vascular MC together with their counts and features. Results showed a significant increase in peri-vascular c-kit+ MC in some asphyxia deaths, such as hanging, strangulation, and aspiration deaths. A strong activation of MC in peri-airway and peri-vascular areas was also observed in lung samples from the anaphylaxis case, which was used as a positive control. Our study points to the potential role of MC in hypoxia and suggests that an evaluation of MC in the lungs may be a useful parameter when forensic pathologists are required to make a differential diagnosis between acute asphyxia deaths and other kinds of death.
Similar content being viewed by others
References
Cecchi R, Sestili, Prosperini G, Cecchetto G, Vicini E, Viel G, Muciaccia B (2014) Markers of mechanical asphyxia: immunohistochemical study on autoptic lung tissues. Int J Legal Med 128(1):117–125
Edston E, Eriksson O, van Hage M (2007) Mast cell tryptase in postmortem serum-reference values and confounders. Int J Legal Med 121(4):275–280
Mekori YA, Metcalfe DD (2000) Mast-cells in innate immunity. Immunol Rev 173:131–140
Norrby K, Jakobsson A, Sörbo J (1986) Mast-cell-mediated angiogenesis: a novel experimental model using the rat mesentery. Virchows Arch B Cell Pathol Incl Mol Pathol 52(3):195–206
Maltby S, Khazaie K, McNagny KM (2009) Mast-cells in Tumor Growth: Angiogenesis, Tissue Remodeling and Immune-modulation. Biochim Biophys Acta 1796(1):19–26
Taylor ML, Metcalfe DD (2001) Mast-cells in allergy and host defense. Allergy Asthma Proc 22(3):115–119
Koshino T, Arai Y, Miyamoto Y, Sano Y, Itami M, Teshima S, Hirai K, Takaishi T, Ito K, Morita Y (1996) Airway basophil and mast cell density in patients with bronchial asthma: relationship to bronchial hyperresponsiveness. J Asthma 33(2):89–95
Anand P, Singh B, Jaggi AS, Singh N (2012) Mast-cells: an expanding pathophysiological role from allergy to other disorders. Naunyn Schmiedeberg's Arch Pharmacol 385:657–670
Mican JM, Metcalfe DD (1990) Arthritis and mast cell activation. J Allergy Clin Immunol 86:677–683
Nigrovic PA, Lee DM (2005) Mast-cells in inflammatory arthritis. Arthritis Res Ther 7(1):1–11
Yano H, Kinuta M, Tateishi H, Nakano Y, Matsui S, Monden T, Okamura J, Sakai M, Okamoto S (1999) Mast cell infiltration around gastric cancer cells correlates with tumor angiogenesis and metastasis. Gastric Cancer 2(1):26–32
Steiner DR, Gonzalez NC, Wood JG (2003) Mast-cells mediate the microvascular inflammatory response to systemic hypoxia. J Appl Physiol 94(1):325–334
Metz M, Grimbaldeston MA, Nakae S, Piliponsky AM, Tsai M, Galli SJ (2007) Mast-cells in the promotion and limitation of chronic inflammation. Immunol Rev 217:304–328
Herget J, Ježek V (1989) Pulmonary hypertension in chronic lung disease. In: Ca W (ed) Pulmonary hypertension problems and controversies. Denolin H. Elsevier Publ Co, Amsterdam, pp 142–162
Norrby K (2002) Mast-cells and angiogenesis. APMIS 110(5):355–371
Maxová H, Herget J, Vízek M (2012) Lung mast-cells and hypoxic pulmonary hypertension. Physiol Res Mar 61(1):1–11
Karakiulakis G, Papakonstantinou E, Aletras AJ, Tamm M, Roth M (2007) Cell type-specific effect of hypoxia and platelet-derived growth factor-BB on extracellular matrix turnover and its consequences for lung remodeling. J Biol Chem 282:908–915
Levick SP, Melendez GC, Plante E, Mclarty JL, Brower GL, Janicki JS (2011) Cardiac mast-cells: the centrepiece in adverse myocardial remodelling. Cardiovasc Res 89(1):12–19
Franceschini B, Ceva-Grimaldi G, Russo C, Dioguardi N, Grizzi F (2006) The complex functions of MASTCELLS in chronic human liver diseases. Dig Dis Sci 51(12):2248–2256
Esposito I, Friess H, Kappeler A, Shrikhande S, Kleeff J, Ramesh H, Zimmermann A, Buchler MW (2001) Mast cell distribution and activation in chronic pancreatitis. Hum Pathol 32(11):1174–1183
Banasova A, Maxova H, Hampl V, Vizek M, Povysilova V, Novotna J, Vajnerova O, Hnilickova O, Herget J (2008) Prevention of mast cell degranulation by disodium cromoglycate attenuates the development of hypoxic pulmonary hypertension in rats exposed to chronic hypoxia. Respiration 76(1):102–107
Nadziejko CE, Loud AV, Kikkawa Y (1989) Effect of alveolar hypoxia on pulmonary mast-cells in vivo. Am Rev Respir Dis 140(3):743–748
Migally NB, Tucker A, Greenlees K, Wright M, Zambernard J (1983) Density and ultrastructure of mast-cells in lung vessels of aging rats exposed to and recovering from chronic hypoxia. Cell Tissue Res 232(3):601–608
Kay JM, Waymire JC, Grover RF (1974) Lung mast cell hyperplasia and pulmonary histamine-forming capacity in hypoxic rats. Am J Physiol 226(1):178–184
Tucker A, Mc Murtry I, Alexander AF, Reeves JT, Grover RF (1977) Lung mast cell density and distribution in chronically hypoxic animals. J Appl Physiol 42(2):174–178
Nakanishi I, Tajima F, Nakamura A, Yagura SY, Ookawara T, Yamashita H, Suzuki K, Taniguchi N, Ohno H (1995) Effects of hypobaric hypoxia on antioxidant enzymes in rats. J Physiol 489(Pt 3):869–876
Hampl V, Herget J (2000) Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension. Physiol Rev 80(4):1337–1372
Lachmanova V, Hnilickova O, Povysilova V, Hampl V, Herget J (2005) N-acetylcysteine inhibits hypoxic pulmonary hypertension most effectively in the initial phase of chronic hypoxia. Life Sci 77(2):175–182
Vajner L, Vytasek R, Lachmanova V, Uhlik J, Konradova V, Novotna J, Hampl V, Herget J (2006) Acute and chronic hypoxia as well as 7-day recovery from chronic hypoxia affects the distribution of pulmonary mast-cells and their MMP-13 expression in rats. Int J Exp Pathol 87(5):383–391
Fineschi V, Cecchi R, Centini F, Pagliacci Reattelli L, Turillazzi E (2001) Immunohistochemical quantification of pulmonary mast cell and post mortem blood dosage of tryptase and eosinophil cationic protein in 48 heroin- related deaths. Forensic Sci Int 120:189–194
Arber DA, Tamayo R, Weiss LM (1998) Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders. Hum Pathol 29(5):498–504
Fukuda T, Kamishima T, Tsuura Y, Suzuki T, Kakihara T, Naito M, Kishi K, Matsumoto K, Shibata A, Seito T (1995) Expression of the c-kit gene product in normal and neoplastic mast-cells but not in neoplastic basophil/mast cell precursors from chronic myelogenous leukaemia. J Pathol 177(2):139–146
Muciaccia B, Sette C, Paronetto MP, Barchi M, Pensini S, D’Agostino A, Gandini L, Geremia R, Stefanini M, Rossi P (2010) Expression of a truncated form of KIT tyrosine kinase in human spermatozoa correlates with sperm DNA integrity. Hum Reprod 25:2188–2202
Lennartsson J, Rönnstrand L (2012) Stem cell factor receptor/c-Kit: from basic science to clinical implications. Physiol Rev 92(4):1619–1649
Gambaryan N, Perros F, Montani D, Cohen-Kaminsky S, Mazmanian GM, Humbert M (2010) Imatinib inhibits bone marrow-derived c-kit + cell mobilisation in hypoxic pulmonary hypertension. Eur Respir J 36(5):1209–1211
Gambaryan N, Perros F, Montani D, Cohen-Kaminsky S, Mazmanian M, Renaud JF, Simonneau G, Lombet A, Humbert M (2011) Targeting of c-kit + haematopoietic progenitor cells prevents hypoxic pulmonary hypertension. Eur Respir J 37(6):1392–1399
Ferranti F, Muciaccia B, Ricci G, Dovere L, Canipari R, Magliocca F, Stefanini M, Catizone A, Vicini E (2012) Glial cell line-derived neurotrophic factor promotes invasive behaviour in testicular seminoma cells. Int J Androl 35:758–768
Hunt LW, Colby TV, Weiler DA, Sur S, Butterfield JH (1992) Immunofluorescent staining for MASTCELLS in idiopathic pulmonary fibrosis: quantification and evidence for extracellular release of mast cell tryptase. Mayo Clin Proc 67(10):941–948
Hawkins RA, Claman HN, Clark RA, Steigerwald JC (1985) Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis. Ann Intern Med 102(2):182–186
Cha SI, Chang CS, Kim EK, Lee JW, Matthay MA, Golden JA, Elicker BM, Jones K, Collard HR, Wolters PJ (2012) Lung mast cell density defines a subpopulation of patients with idiopathic pulmonary fibrosis. Histopathology 61:98–106
Van der Veer WM, Bloemen MC, Ulrich MM, Molema G, Van Zuijlen PP, Middelkoop E, Niessen FB (2009) Potential cellular and molecular causes of hypertrophic scar formation. Burns 35:15–29
Inoue Y, King TE Jr, Tinkle SS, Dockstader K, Newman LS (1996) Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders. Am J Pathol 149:2037–2054
Corallini S, Fera S, Grisanti L, Falciatori I, Muciaccia B, Stefanini M, Vicini E (2006) Expression of the adaptor protein m-Numb in mouse male germ cells. Reproduction 132:887–897
Du Chesne A, Cecchi R, Püschel K, Brinkmann B (1996) Macrophage subtype patterns in protracted asphyxiation. Int J Legal Med 109:163–166
Betz P, Nerlich A, Penning R, Eisenmenger W (1993) Alveolar macrophages and the diagnosis of drowning. Forensic Sci Int 63:217–224
Betz P, Beier G, Eisenmenger XW (1994) Pulmonary giant cells and traumatic asphyxia. Int J Legal Med 106:258–261
Vacchiano G, D'Armiento F, Torino R (2001) Is the appearance of macrophages in pulmonary tissue related to time of asphyxia? Forensic Sci Int 115:9–14
Vacchiano G (2002) Letter to the Editor. Role of pulmonary macrophages and giant cells in fatal asphyxia. Forensic Sci Int 127:245
Wilcox JN, Okamoto EI, Nakahara KI, Vinten-Johansen J (2001) Perivascular responses after angioplasty which may contribute to postangioplasty restenosis: a role for circulating myofibroblast precursors? Ann NY Acad Sci 947:68–90
Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM (2002) Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109(3):337–346
Angelini DJ, Su Q, Kolosova IA, Fan C, Skinner JT, Yamaji-Kegan K, Collector M, Sharkis SJ, Johns RA (2010) Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMa) recruits bone marrow-derived cells to the murine pulmonary vasculature. PLoS ONE 5(6):e11251
Montani D, Perros F, Gambaryan N, Girerd B, Dorfmuller P, Price LC, Huertas A, Hammad H, Lambrecht B, Simonneau G, Launay JM, Cohen-Kaminsky S, Humbert M (2011) C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension. Am J Respir Crit Med 184(1):116–123
Dahlin JS, Hallgren J (2015) Mast cell progenitors: origin, development and migration to tissue. Mol Immunol 63:9–17
Hallgren J, Gurish MF (2011) Mast cell progenitor trafficking and maturation. Adv Exp Med Biol 716:14–28
Hallgren J, Jones TG, Abonia JP, Xing W, Humbles A, Austen KF, Gurish MF (2007) Pulmonary CXCR2 regulates VCAM-1 and antigen-induced recruitment of mast cell progenitors. Proc Natl Acad Sci USA 104(51):20478–20483
Chao J, Donham P, Van Rooijen N, Wood JG, Gonzalez NC (2011) Monocyte chemoattractant protein-1 released from alveolar macrophages mediates the systemic inflammation of acute alveolar hypoxia. Am J Respir Cell Mol Biol 45(1):53–61
Walczak-Drzewiecka A, Ratajewski M, Wagner W, Dastych J (2008) HIF-1alpha is up-regulated in activated mast-cells by a process that involves calcineurin and NFAT. J Immunol 181(3):1665–1672
Reszec J, Hermanowicz A, Rutkowski R, Bernaczyk P, Mariak Z, Chyczewski L (2013) Evaluation of mast cells and hypoxia inducible factor-1 expression in meningiomas of various grades in correlation with peritumoral brain edema. J Neuro-Oncol 115(1):119–125
Jeong HJ, Oh HA, Nam SY, Han NR, Kim YS, Kim JH, Lee SJ, Kim MH, Moon PD, Kim HM, Oh HA (2013) The critical role of mast cell-derived hypoxia-inducible factor-1α in human and mice melanoma growth. Int J Cancer 132(11):2492–2501
Gulliksson M, Carvalho RF, Ulleras E, Nilsson G (2010) Mast cell survival and mediator secretion in response to hypoxia. PLoS One 5, e12360
Acknowledgments
Authors followed accepted principles of ethical and professional conduct. No sources of funding were given for the study, and no informed consent has to be given.
Conflict of interest
Disclosure of potential conflict of interest is given in a separate file.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Muciaccia, B., Sestili, C., De Grossi, S. et al. Are mast cells implicated in asphyxia?. Int J Legal Med 130, 153–161 (2016). https://doi.org/10.1007/s00414-015-1211-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00414-015-1211-5